News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
H. Moses Murdock: How I Treat AML relapse after allogeneic HCT
H. Moses Murdock, Mahasweta Gooptu and Robert Soiffer
Jan 10, 2025, 23:34

H. Moses Murdock: How I Treat AML relapse after allogeneic HCT

H. Moses Murdock, Hematology/Oncology fellow at Dana-Farber Cancer Institute, shared a post on X about a recent review article by him and colleagues, published in Blood:

“Excited to share our new manuscript co-authored by Dana-Farber Cancer Institute BMT mentors Dr. Gooptu and Dr. Soiffer: How I Treat AML relapse after allogeneic HCT.

No one-size-fits-all approach to this challenging situation learned a ton writing it!”

“How I Treat AML relapse after allogeneic HCT”

Authors: Mahasweta Gooptu, H. Moses Murdock, Robert Soiffer.

H. Moses Murdock: How I Treat AML relapse after allogeneic HCT
Acute Myeloid Leukaemia AML blood cancer Dana-Farber Cancer Institute H. Moses Murdock Mahasweta Gooptu OncoDaily Oncology Robert Soiffer
Special Coverage
Blog
Jan 11, 2025, 07:16
Applications open for the MCCR workshop - EORTC
Blog
Jan 11, 2025, 06:45
Chinmay Jani: Exploring trends in tracheal, bronchial, and lung cancer mortality
Insight
Jan 11, 2025, 06:35
Loay Kassem: Six studies that could change my breast cancer practice based on SABCS 2024
Blog
Jan 11, 2025, 03:11
Esosa Omoregie: I am now a proud member of the Association of Southeastern Biologists
Science
Jan 10, 2025, 23:34
H. Moses Murdock: How I Treat AML relapse after allogeneic HCT
Science
Jan 10, 2025, 22:45
Role of iron in pathophysiology of MDS, in a preclinical model by Ada Antypiuk et al.
Blog
Jan 10, 2025, 22:38
Jaehyuk Choi: I am joining the University of Texas Southwestern
Science
Jan 10, 2025, 22:28
Chris Labaki: Exploring immunogenomic determinants of exceptional response to ICI in ccRCC
Science
Jan 10, 2025, 21:10
Arndt Vogel: TACE combined with lenvatinib and pembrolizumab vs placebo for intermediate HCC
Science
Jan 10, 2025, 20:10
Senthil Kumar: First-Line Therapy for Metastatic Pancreatic Cancer
Blog
Jan 10, 2025, 20:04
Chandandeep Kaur: Everything that you need to know about the basics of cancer science
Insight
Jan 10, 2025, 19:51
Uma Borate: Reducing Clinical Trial Eligibility Barriers for MDS